Responsive Neurostimulation For Loss Of Control Eating
Summary
The primary objective of this trial is to assess device function and safety, with secondary objectives including the feasibility. The study involves the use of responsive neurostimulation and will assess clinical outcomes in participants with Loss of Control Eating. This research aims to generate evidence that could support future development and regulatory approval of innovative neurotechnology-based treatments for affected patients.
Why it matters
This trial represents an important advancement in neurotechnology for treating Loss of Control Eating. If successful, the device-based intervention could provide a new therapeutic option for patients who have not responded adequately to conventional treatments or therapies. The study results may inform future regulatory approval pathways and establish clinical precedent that could benefit broader patient populations with similar conditions.
Want the full NeurotechMag Pro intelligence database?
Access 800+ papers, trials, patents, funding rounds and news items — updated daily.
Start free trial